000			01484 a2200445 4500
005			20250511132142.0
264		0	_c19771031
008			197710s 0 0 eng d
022			_a0025-7125
024	7		_a10.1016/s0025-7125(16)31278-0 _2doi
040			_aNLM _beng _cNLM
100	1		_aChang, P
245	0	0	_aProgress in the treatment of osteosarcoma. _h[electronic resource]
260			_bThe Medical clinics of North America _cSep 1977
300			_a1027-38 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Review
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAmputation, Surgical
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aBone Neoplasms _xpathology
650	0	4	_aCell Division
650	0	4	_aChild
650	0	4	_aClinical Trials as Topic
650	0	4	_aDoxorubicin _xtherapeutic use
650	0	4	_aDrug Therapy, Combination
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLeucovorin _xtherapeutic use
650	0	4	_aLung Neoplasms _xpathology
650	0	4	_aMale
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aNeoplasm Metastasis
650	0	4	_aOsteosarcoma _xpathology
650	0	4	_aPrognosis
650	0	4	_aRadiotherapy, High-Energy
650	0	4	_aTime Factors
773	0		_tThe Medical clinics of North America _gvol. 61 _gno. 5 _gp. 1027-38
856	4	0	_uhttps://doi.org/10.1016/s0025-7125(16)31278-0 _zAvailable from publisher's website
999			_c429194 _d429194